{"disease":{"id":"bullous-dermatoses","name":"bullous dermatoses"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05406908","title":"Intradermal Tozinameran for Patients With Immune-mediated Dermatologic Diseases","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":109,"lead_sponsor_name":"Mahidol University","has_results":false},{"nct_id":"NCT04096222","title":"Comparative Analysis of the Th17 Cellular Response in Active and Inactive Pemphigus Vulgaris Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":42,"lead_sponsor_name":"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}